DWTX

Dogwood Therapeutics, Inc. is an innovative biotechnology firm headquartered in Alpharetta, Georgia, dedicated to developing advanced antiviral therapies that target diseases linked to dysregulated immune responses from viral infections. The company boasts a robust pipeline of novel therapeutic candidates, leveraging state-of-the-art research to transform treatment approaches in the antiviral landscape. As Dogwood Therapeutics advances through preclinical and clinical stages, it aims to significantly improve patient outcomes and solidify its position as a leader in combating viral diseases.